• OPEN AN ACCOUNT
Indian Indices
Nifty
25,239.10 169.90
(0.68%)
Sensex
82,380.69 594.95
( 0.73%)
Bank Nifty
55,147.60 259.75
( 0.47%)
Nifty IT
36,212.15 310.00
( 0.86%)
Global Indices
Nasdaq
45,773.62 130.84
(-0.29%)
Dow Jones
6,626.82 -9.46
(-0.14%)
Hang Seng
44,932.94 164.82
(0.37%)
Nikkei 225
9,195.66 -81.37
(-0.88%)
Forex
USD-INR
88.27 0.00
(0.00%)
EUR-INR
103.57 0.18
(0.18%)
GBP-INR
119.65 0.10
(0.08%)
JPY-INR
0.60 0.00
(-0.17%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
397.3891536
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
24.36
125868.28
EPS(TTM)
Face Value()
Div & Yield %
63.96
2
1.03
 

Dhansafal Finserve Ltd - Board Meeting Outcome for Outcome Of The Board Meeting Held On August 14 2025.
Aug 14,2025
Board of Directors of the Company at its Meeting held today i.e. Thursday August 14 2025 have inter-alia considered and approved 1. Unaudited Financial Results for the quarter ended June 30 2025 2. Resignation of M/s. RSRV & Associates Chartered Accountants the Statutory Auditors of the Company. 3. Appointment of M/s. ARCK & Co. Chartered Accountants as the Statutory Auditor of the Company. 4. Appointment of Mr. Raghunath Patel as a Non-Executive Independent Director on the Board of the Company. 5. Draft Notice convening 44th AGM of the Company to be held on September 25 2025. 6. Shifting of Registered Office of the Company to G -1402 Lotus Corporate Park Jay Coach Area Goregaon East Mumbai 400063 wef August 15 2025.